Skip to main content

J&J's $4.7B Talc Verdict Bid: Jurisdiction Questions Rose

J&J's $4.7B Talc Verdict Bid: Jurisdiction Questions Rose

J&J's $4.7B Talc Verdict Bid: Jurisdiction Questions Rose

Introduction

On Friday, Thomas Weaver, the attorney representing Johnson & Johnson (J&J) argued over a bid to reverse a jury’s $4.7 billion talcum powder verdict stating that the judge should not have combined all the 22 claims, particularly the 17 plaintiffs from Missouri, into a single trial.

The case involves a group of ovarian cancer victims and their family members, led by a plaintiff. The case ended with a $4.69 verdict in June 2018, after a six-week trial. Each woman or family was awarded $25 million in compensatory damages, along with $4.14 billion total in punitive damages, of which $3.15 billion was against J&J and $990 million against its subsidiary J&J Consumer Inc.

J&J also raised various other issues with plaintiffs’ experts, including William Longo, founder of Materials Analytical Services.

However, the panel of three judges seemed skeptical over challenging 22nd Circuit Judge Rex Burlison’s consolidation order or the reasoning behind the jury’s record award.

Previously, the Missouri Court of Appeals had reversed a $110 million award involving Bristol-Myers because the plaintiff was from Virginia and also reversed verdicts of $72 million, $70 million, and $55 million on similar grounds.

Due to the pandemic crisis, only two attorneys for either side were permitted in the courthouse, and the gallery was empty. The spectators were able to watch the arguments via a live video on the court’s Facebook page.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.